Dentsply Sirona (XRAY) fundamentals: P/E, valuation, undervalued?
Dentsply Sirona · Health Care · ref. ETF XLV · price $8.51
In short — Dentsply Sirona trades at —× earnings (P/E), 5.7× forward, with a net margin of -15.0 % and revenue growth of -4 %. Read: Not (yet) profitable (valued on growth, not earnings).
Is Dentsply Sirona stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$8.51-31.8% over range
Oct 14, 25low $8.51 · high $14.68Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
20% recommend buying · 5 analysts
Valuation : Not (yet) profitable — valued on growth, not earnings
Valuation
—
P/E (price/earnings)
5.7
Forward P/E
—
PEG
1.3
Price/book (P/B)
$1.7B
Market cap
-2.73
EPS
Profitability & growth
-15.0 %
Net margin
-4 %
Revenue growth
—
Earnings growth
$2.3B
Total debt
Dentsply Sirona income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2022 | $3.9B | $-950M | -24.2 % |
| 2023 | $4.0B | $-132M | -3.3 % |
| 2024 | $3.8B | $-910M | -24.0 % |
| 2025 | $3.7B | $-598M | -16.3 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is Dentsply Sirona's P/E and is the stock undervalued? What's a good P/E?
Dentsply Sirona's P/E is — (forward 5.7). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Not (yet) profitable".
Is Dentsply Sirona profitable?
Dentsply Sirona has a net margin of -15.0 % (EPS -2.73). The company is not (yet) profitable.
Is XRAY stock expensive?
Our read: "Not (yet) profitable" — valued on growth, not earnings. Cross-check with growth and sector.
💬 A question about Dentsply Sirona? The JPI assistant answers using our backtest data.